Used primarily in pharmaceutical research and development, this compound serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both an aminomethyl group and a trifluoromethyl group, makes it valuable for designing molecules with enhanced biological activity and metabolic stability. It is particularly useful in the development of drugs targeting central nervous system disorders, inflammation, and certain types of cancers. Additionally, its benzonitrile moiety allows for further functionalization, enabling the creation of diverse chemical libraries for drug discovery.